JP Patent

JP6151413B2 — 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠

Assigned to Sumitomo Pharma Co Ltd · Expires 2017-06-21 · 9y expired

What this patent protects

Patent listed against naldemedine-tosylate.

Drugs covered by this patent

naldemedine-tosylate (NALDEMEDINE TOSYLATE)

Patent Metadata

Patent number: JP6151413B2
Jurisdiction: JP
Classification: —
Expires: 2017-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.